Cochlear Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Cochlear Stock Forecast and Price Target
Cochlear has an average price target of $288.00 recently offered by notable experts for 2024, which would represent a potential downside of approximately -14.19% from the last closing price in March, 2024 if reached. This potential increase is based on a high estimate of $365.00 and a low estimate of $220.00. Even if you are not interested in COH stock, you should still be aware of its competitors.
-14.19% Downside
Cochlear Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Cochlear's Price has fallen from $139.50 to $0.00 – a 100.00% decrease. Next year, analysts are expecting Fair Value to reach $302.25 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ANN Stock Forecast | Ansell | Hold |
16
|
$23.39 | Buy/Sell | $15.96 | -29.03% |
AHY Stock Forecast | Essity AustralAsia | - |
15
|
$1.42 | Buy/Sell | $1.34 | -100.00% |
AVR Stock Forecast | Anteris Technologies Ltd | Buy |
10
|
$19.20 | Buy/Sell | $28.00 | 45.83% |
AT1 Stock Forecast | Atomo Diagnostics | - |
0
|
$0.03 | Buy/Sell | $0.11 | -100.00% |
HGV Stock Forecast | Hygrovest | - |
0
|
$0.05 | Buy/Sell | $0.00 | -100.00% |
Cochlear Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Cochlear's Revenue has grown from $1.32B to $1.94B – a 46.61% increase. Next year, analysts are expecting Revenue to reach $2.18B – an increase of 12.71%. Over the next seven years, the forecast is for Revenue to grow by 87.54%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MCT Stock Forecast | Metalicity | - |
3
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
ALT Stock Forecast | Analytica | - |
2
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
AMT Stock Forecast | Allegra Medical Technologies | - |
4
|
$0.03 | Buy/Sell | $0.00 | -100.00% |
Cochlear Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Cochlear's Dividend per Share has grown by 106.25%, rising from $1.60 to $3.30. For next year, analysts predict Dividend per Share of $3.90, which would mean an increase of 18.18%. Over the next eight years, experts predict that Cochlear's Dividend per Share will grow at a rate of 127.27%.
Cochlear EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Cochlear's EBITDA has grown, rising from $259.60M to $447.90M – a growth of 72.53%. In the next year, analysts believe that EBITDA will reach $566.18M – an increase of 26.41%. For the next seven years, the forecast is for EBITDA to grow by 133.53%.
Cochlear EBIT Forecast for 2023 - 2025 - 2030
Cochlear's EBIT has grown In the last three years, rising from $221.30M to $406.30M – a growth of 83.60%. In the next year, analysts believe that EBIT will reach $482.39M – an increase of 18.73%. For the next seven years, experts predict that Cochlear's EBIT will grow at a rate of 130.86%.
Cochlear EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Cochlear's EPS has fallen from $2.58 to $0.00 – a 100.00% decrease. Next year, analysts are expecting EPS to reach $5.59 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.